Total delay and associated factors among tuberculosis patients in Jimma Zone, Southwest Ethiopia
Peer reviewed, Journal article
Published version

View/ Open
Date
2023Metadata
Show full item recordCollections
Original version
10.1371/journal.pone.0281546Abstract
Background
Delays in diagnosis and treatment of tuberculosis (TB) increases severity of illness and con-
tinued transmission of TB in the community. Understanding the magnitude and factors asso-
ciated with total delay is imperative to expedite case detection and treatment of TB. The aim
of this study was to determine the length and analyze factors associated with total delay.
Methods
Analytic cross-sectional study was conducted in Jimma Zone, Southwest Ethiopia. All newly
diagnosed TB patients > 15 years of age were included from randomly selected eight dis-
tricts and one town in the study area. A structured questionnaire was applied to collect
socio-demographic and clinical data. The median total delay was used to dichotomize the
sample into delayed and non-delayed patient categories. Logistic regression analysis was
used to analyse the association between independent and outcome variables. A p-value <
0.05 were considered statistically significant.
Results
A total of 1,161 patients were included in this study. The median total delay was 35 days.
Patients who had swelling or wound in the neck region were more likely to be delayed than
their counterpart [adjusted odds ratio (AOR) = 3.02, 95% confidence interval (CI): 1.62,
5.62]. Women were more likely to experience longer total delay (AOR = 1.46, 95% CI:1.00,
2.14) compared to men. Patients who had poor knowledge of TB were more likely to be
delayed compared to those who had good knowledge (AOR = 3.92, 95% CI: 2.65, 5.80).
Conclusion
The present study showed long total delay in diagnosis and treatment of TB. Targeted inter-
ventions that enhance TB knowledge and practice, expedite early suspect identification,
referral and management of all forms of TB is imperative to reduce total delay in diagnosis
and treatment of TB.